Drug development is complex and costly.  Implementing best practices in bioanalysis, risk assessment, and compliance are critical to success.  Our consulting services can help you build a solid foundation for decision making. 
Dr. Erik Foehr is a biotechnology professional with over a decade of experience in regulated bioanalysis, immunogenicity assessment, drug development and medical device characterization.  Dr. Foehr actively publishes his work and speaks at national and international conferences.  This experience gives him a unique view of the challenges of drug development and benefits of building a solid understanding of a therapeutics liabilities and benefits.